AzTrials
AzTrials

Nutrition Deficiency Due to Insufficient FoodAdonutNCT06444555

Adolescent Nutrition in Girls in Burkina Faso and Ethiopia

A study testing BEP supplement and Multiple Micronutrient supplement in people with Nutrition Deficiency Due to Insufficient Food, run by University Ghent at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Adolescents' diets are key to breaking the intergenerational cycle of malnutrition. This study will guide policies and programs on the adequacy, acceptability, and feasibility of implementing balanced energy protein and multiple micronutrient supplementations to fill nutrient gaps in adolescent girls. Read more about this study

Who is it for?
Ages 15 to 19 years, women onlyHealthy volunteers can take part
What is being tested?
BEP supplement and Multiple Micronutrient supplement
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
2 sitesin 2 countries
Study dates
28 May 2024to 5 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 19 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Non-pregnant and non-lactating women
  • Without any known chronic illness or acute illness affecting appetite
  • Permanent residents of the study area

Who cannot join

  • Being allergic to peanuts
  • Eating disorders or dietary restrictions

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Burkina Faso1 site
  • Agence de Formation, de Recherche et d'Expertise en Santé pour l'Afrique (AFRICSanté)

    Bobo-Dioulasso

Other trials in Burkina Faso

Ethiopia1 site
  • Addis Continental Institute of Public Health

    Addis Ababa

Other trials in Ethiopia

About this study

Official title: Nutritional Needs and Food Supplement Intake of Adolescent Girls in Burkina Faso and Ethiopia

Adolescents' diets are key to breaking the intergenerational cycle of malnutrition. This study will guide policies and programs on the adequacy, acceptability, and feasibility of implementing balanced energy protein and multiple micronutrient supplementations to fill nutrient gaps in adolescent girls. Using a trial, the study will assess dietary intake and nutrient gaps, acceptability of balanced energy protein and multiple micronutrient supplementations. In addition to the trial, the study will the assess willingness to pay for the supplements and the most effective delivery platform and model to reach vulnerable adolescent girls. The most effective delivery platform and model to reach vulnerable adolescent girls cost-effectively will also be assessed through interviews with (inter)national experts, producers, and the donor community.

Read the detailed description

In low- and middle-income countries, it is estimated that each year, 21 million adolescent girls become mothers. Infants of adolescent mothers are at increased risk of delivering babies preterm, with low birth weight or length. Targeting nutrition interventions to improve adolescent girls' diet and nutrition is crucial to breaking the intergenerational cycle of poor growth and development. There is a specific need to assess how a balanced energy protein (BEP) and multiple micronutrient (MMN) supplement interventions can be tailored to adolescent girls and women of reproductive age.

This study aims to assess the adequacy, acceptability, and feasibility of implementing nutritional supplementations to fill nutrient gaps in adolescent girls in resource-limited settings. A trial will specifically:

  1. assess the short-term acceptability of BEP and MMN supplements
  2. assess how nutrition supplements increase nutrient adequacy of diets adolescent girls in resources-limited settings;

Using a qualitative component, the study explores the food agency of adolescents and the most effective delivery platform to reach vulnerable adolescent girls cost-effectively. The overall aim is to guide policies and programs on new formulations of nutritional supplements for adolescent girls in resource-limited settings.

Being tested
BEP supplement, Multiple Micronutrient supplement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BEP supplementDietary supplement

    Also called Balanced energy protein supplement

    The BEP supplement used in Burkina Faso is a fortified medium-quantity lipid-based nutrient supplement called Plumpy'Doz. The product is a peanut and milk-based ready-to-use nutritional formulation produced by Nutriset. A peanut-based BEP formulation with a trademark Plumpy'Sup produced by Hilina Enriched Foods PLC will be used in Ethiopia.

  • Multiple Micronutrient supplementDietary supplement

    Also called UNIMAPP

    The MMN formulation is based on the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP). The formulation contains 15 minerals and vitamins and is administered as a tablet.

Study groups in NCT06444555
Study groupRoleWhat they receive
Balanced Energy Protein SupplementExperimentalFortified lipid-based nutrient supplement
Receives: Dietary Supplement: BEP supplement
Multiple Micronutrient SupplementActive comparatorThe United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP).
Receives: Dietary Supplement: Multiple Micronutrient supplement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of the supplement

    Acceptability to the nutritional supplements, as measured using a 9-item scale (1 "Dislike extremely" up to 9 "Like extremely")

    Measured: Day 8 (after 7 days of consumption)

  2. Nutritional adequacy

    Mean nutrient adequacy ratio of adolescent diets, using 24 h recall

    Measured: Day 8 (after 7 days of consumption)

Secondary outcomes (4)
  1. Willingness to pay for the supplement

    Mean household head's willingness to pay values elicited through their bids

    Measured: Day 8 (after 7 days of consumption)

  2. Reported consumption of the supplement

    Percent of the recommended nutritional supplement consumed during the intervention period, self-reported

    Measured: Day 8 (average of 7-day intervention)

  3. Substitution of food and nutrient intake

    Substitution of food and nutrition intake at group level, using 24 h recall

    Measured: Day 8 (after 7 days of consumption)

  4. Nutrient intake

    Mean energy, macronutrient and micronutrient intake between the BEP and MMN group, using 24 h recall

    Measured: Day 8 (after 7 days of consumption)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2024
  2. Study start28 May 2024
  3. Primary completion5 Jul 2024
  4. Study completion5 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
200 adolescent girls will be enrolled in Ethiopia and 200 adolescent girls will be enrolled in Burkina Faso.
Masking
None (open label)
Enrolment
400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06444555
Sponsor's protocol ID
ONZ-2024-0038
Acronym
Adonut
Status last verified
Sep 2024
First submitted
21 May 2024
Last updated
23 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be transferred to the donor in a pseudo-anonymised way. After preparing a data-sharing agreement, the investigators will also share food intake data with the Food and Agriculture Organization and World Health Organization (FAO/WHO) of the United Nations Global Individual Food Consumption Data Tool. All research output generated by the project is open access as part of the Grant Agreement with the funder. Given the personal nature of the data, individual data will only be shared after a data transfer agreement with third parties. The informed consent form mentions that data can be shared outside the study team.

Questions about this trial

What is this clinical trial studying?

A study testing BEP supplement and Multiple Micronutrient supplement in people with Nutrition Deficiency Due to Insufficient Food, run by University Ghent at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Burkina Faso, Ethiopia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of the supplement (time frame: Day 8 (after 7 days of consumption)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in